SCHEMBL7794763

SCHEMBL7794763

Cc1snnc1C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2208458 0.79
SCHEMBL12860999 0.79
SCHEMBL8575268 0.74 ALDH1A1 (0.49)
SCHEMBL6816463 0.74 NPSR1 (0.48)
SCHEMBL7464632 0.70 RAB9A (0.46)
SCHEMBL10918558 0.68 MAPT (0.35)
SCHEMBL7662839 0.66 MAPT (0.49)
SCHEMBL7015920 0.64 PPARD (0.35)
SCHEMBL3056401 0.62
SCHEMBL11596189 0.62 CA12 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104530037-B Triazine heterocyclic compound with nematicidal activity and preparation method and application thereof 华东理工大学 2020-12-18 CN disclosed
WO-2016116058-A1 TRIAZINE HETEROCYCLIC COMPOUND WITH NEMATICIDAL ACTIVITY AND PREPARATION METHOD THEREFOR AND USAGE THEREOF 华东理工大学 2016-07-28 WO disclosed
US-20010031760-A1 Method of treating a patient having precancerous lesions with quinazoline derivatives PAMUKCU RIFAT (US) 2001-10-18 US disclosed
US-6262059-B1 Method of treating a patient having precancerous lesions with quinazoline derivatives CELL PATHWAYS, INC. 2001-07-17 US disclosed
US-4171363-A HYPOTENSIVE BRISTOL-MYERS COMPANY (US) 1979-10-16 US disclosed
US-4101548-A HYPOTENSIVE BRISTOL-MYERS COMPANY (US) 1978-07-18 US disclosed